Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Interesting SAGE Put And Call Options For February 2018

Investors in Sage Therapeutics Inc saw new options become available this week, for the February 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay,...

SAGE : 84.23 (-0.84%)
5 Top Stocks to Own

Today I sorted Barchart's Top Stocks to Own list first by the highest Weighted Alpha, then by technical buy signals of 80% or more and lastly used the FlipChart feature to review the charts...

ENZ : 11.54 (+4.72%)
TDOC : 36.00 (+3.90%)
NVTR : 12.87 (-4.53%)
SAGE : 84.23 (-0.84%)
PI : 58.79 (+7.58%)
Noteworthy Friday Option Activity: SAGE, BV, ALGN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sage Therapeutics Inc , where a total of 1,576 contracts have traded so far, representing approximately...

SAGE : 84.23 (-0.84%)
Sage Therapeutics to Present at Goldman Sachs Healthcare Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 84.23 (-0.84%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on June...

SAGE : 84.23 (-0.84%)
Sage Therapeutics Receives Fast Track Designation for SAGE-217 for the Treatment of Major Depressive Disorder

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 84.23 (-0.84%)
Sage Therapeutics Announces First Quarter 2017 Financial Results and Provides Pipeline Update

--Advancing SAGE-217 into Part B open-label Phase 2 trial in Parkinson's disease based on initial activity signal

SAGE : 84.23 (-0.84%)
Investor Network: SAGE Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 9, 2017 / SAGE Therapeutics, Inc. (NASDAQ: SAGE) will be discussing their earnings results in their Q1 Earnings Call to be held May 9, 2017 at 4:30 PM Eastern Time.

SAGE : 84.23 (-0.84%)
How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

On Tuesday, April 25, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Tuesday's trading session in bullish...

BNTC : 1.91 (-6.37%)
CBAY : 5.56 (+8.38%)
SAGE : 84.23 (-0.84%)
CBIO : 4.53 (+0.44%)
BNIKF : 0.1110 (+12.12%)
Sage Therapeutics to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that...

SAGE : 84.23 (-0.84%)
Sage Therapeutics Appoints Michael Cloonan as Chief Business Officer and Expands Executive Team

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the appointment...

SAGE : 84.23 (-0.84%)
5 Drug Stocks for Your Portfolio this World Health Day

With "Depression: let's talk" being this year's World Health Day campaign slogan, here's a look at 5 companies developing treatments for various types of depression.

JNJ : 136.43 (+0.28%)
AGN : 246.46 (-0.26%)
SAGE : 84.23 (-0.84%)
ALKS : 58.47 (-0.36%)
VTGN : 1.77 (-1.67%)
First Week of November 17th Options Trading For Sage Therapeutics (SAGE)

Investors in Sage Therapeutics Inc saw new options become available this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the...

SAGE : 84.23 (-0.84%)
Pershing Gold to Present at 2017 European Gold Forum

Pershing Gold Corporation (NASDAQ:PGLC) (TSX: PGLC) (FWB:7PG1) ("Pershing Gold" or the "Company"), the emerging Nevada gold producer advancing the Relief Canyon Mine, today announced that Stephen Alfers...

PGLC.TO : 3.73 (+0.81%)
SAGE : 84.23 (-0.84%)
PGLC : 2.86 (+2.14%)
Pershing Gold to Present at 2017 European Gold Forum

Pershing Gold Corporation (NASDAQ:PGLC) (TSX: PGLC) (FWB:7PG1) ("Pershing Gold" or the "Company"), the emerging Nevada gold producer advancing the Relief Canyon Mine, today announced that Stephen Alfers...

PGLC.TO : 3.73 (+0.81%)
SAGE : 84.23 (-0.84%)
PGLC : 2.86 (+2.14%)
Are Options Traders Betting on a Big Move in Sage Therapeutics (SAGE) Stock?

Options Traders are Betting on a Big Move in Sage Therapeutics (SAGE) Stock on the back of its huge implied volatility.

SAGE : 84.23 (-0.84%)
Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

On Thursday, March 23, 2017, the NASDAQ Composite ended the trading session at 5,817.69, down 0.07%; the Dow Jones Industrial Average edged 0.02% lower, to finish at 20,656.58; and the S&P 500 closed at...

BNTC : 1.91 (-6.37%)
BDSI : 2.95 (+3.51%)
SAGE : 84.23 (-0.84%)
OGXI : 0.34 (+3.03%)
BNIKF : 0.1110 (+12.12%)
Option Trades: Covered Call reports for American Airlines, Alnylam Pharmaceuticals, The Kroger Co, Resolute Energy Corporation and Sage Therapeutics include trade ideas that offer returns of 25% or more!

InvestorsObserver issues critical PriceWatch Alerts for AAL, ALNY, KR, REN, and SAGE.

KR : 22.60 (+0.18%)
ALNY : 85.21 (+1.49%)
REN : 28.90 (+4.37%)
SAGE : 84.23 (-0.84%)
AAL : 48.63 (-0.69%)
Blog Coverage La Jolla's Lead Product Candidate LJPC-501 Posts Positive Phase-III Trial Results

Upcoming AWS Coverage on Sage Therapeutics Post-Earnings Results

LJPC : 30.42 (+3.96%)
SAGE : 84.23 (-0.84%)
Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

--Phase 2 placebo-controlled study of SAGE-217 in major depressive disorder expected to begin in 1H 2017

SAGE : 84.23 (-0.84%)

Van Meerten Stock Picks

5 Great Growth Stocks
Each week Value Line publishes a list of growth stocks the for the past 10 years have had a 10% increase in Sales, Cash Flow, Earnings, Dividends and Book Value and are expected to continue that 10% growth for the next 5 years.
NVDA -4.54 , CGNX +1.13 , EDU +0.07 , LUV +0.40 , ZBRA +0.17
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Sep E-mini S&Ps ( ESU17 +0.26%) this morning are up +0.22% and European stocks are up +0.98% on signs of increased M&A activity along with a rally in European bank stocks. Nestle SA is up nearly 5% after Third... Read More

Chart of the Day

LendingTree (TREE) is the Barchart Chart of the Day. The mortgage lender has a Trend Spotter buy signal, A weighted Alpha of 147.70+ and gained 129.77% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures ended the week with losses of 3 1/4 to 5 1/2 cents, with July down 6.84% since last Friday. Friday’s Commitment of traders report showed spec funds adding back 35,896 contracts to their net short position as of Tuesday, after last ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.